The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Virus Cryopreservation Market Research Report 2025
Synopsis
Virus cryopreservation is a biotechnology that allows long-term preservation of virus in living tissues or in suspension medium by freezing them at very low temperatures, usually below -70°C. The aim of virus cryopreservation is to maintain the viability and infectivity of the virus without altering its genetic stability. Virus cryopreservation requires the use of cryo-protectant agents, such as glycerol, dimethyl sulfoxide (DMSO) or fetal bovine serum (FBS), to prevent ice crystal formation and damage to the virus structure.
Global Virus Cryopreservation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Virus Cryopreservation market research.
Key manufacturers engaged in the Virus Cryopreservation industry include ATCC, Kerafast, Virovek, Virusys Corporation, Microbix Biosystems, Eureka Therapeutic, Vigene Biosciences, Oxford Biomedica and Cobra Biologics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Virus Cryopreservation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Virus Cryopreservation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Virus Cryopreservation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ATCC
Kerafast
Virovek
Virusys Corporation
Microbix Biosystems
Eureka Therapeutic
Vigene Biosciences
Oxford Biomedica
Cobra Biologics
Lonza
BioReliance
Segment by Type
Plant Virus Freezing Solution
Animal Virus Freezing Solution
Segment by Application
Medical
Scientific Research
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Virus Cryopreservation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Virus cryopreservation is a biotechnology that allows long-term preservation of virus in living tissues or in suspension medium by freezing them at very low temperatures, usually below -70°C. The aim of virus cryopreservation is to maintain the viability and infectivity of the virus without altering its genetic stability. Virus cryopreservation requires the use of cryo-protectant agents, such as glycerol, dimethyl sulfoxide (DMSO) or fetal bovine serum (FBS), to prevent ice crystal formation and damage to the virus structure.
Global Virus Cryopreservation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Virus Cryopreservation market research.
Key manufacturers engaged in the Virus Cryopreservation industry include ATCC, Kerafast, Virovek, Virusys Corporation, Microbix Biosystems, Eureka Therapeutic, Vigene Biosciences, Oxford Biomedica and Cobra Biologics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Virus Cryopreservation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Virus Cryopreservation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Virus Cryopreservation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ATCC
Kerafast
Virovek
Virusys Corporation
Microbix Biosystems
Eureka Therapeutic
Vigene Biosciences
Oxford Biomedica
Cobra Biologics
Lonza
BioReliance
Segment by Type
Plant Virus Freezing Solution
Animal Virus Freezing Solution
Segment by Application
Medical
Scientific Research
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Virus Cryopreservation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Virus Cryopreservation Market Overview
1.1 Product Overview and Scope of Virus Cryopreservation
1.2 Virus Cryopreservation Segment by Type
1.2.1 Global Virus Cryopreservation Market Value Comparison by Type (2023-2029)
1.2.2 Plant Virus Freezing Solution
1.2.3 Animal Virus Freezing Solution
1.3 Virus Cryopreservation Segment by Application
1.3.1 Global Virus Cryopreservation Market Value by Application: (2023-2029)
1.3.2 Medical
1.3.3 Scientific Research
1.4 Global Virus Cryopreservation Market Size Estimates and Forecasts
1.4.1 Global Virus Cryopreservation Revenue 2018-2029
1.4.2 Global Virus Cryopreservation Sales 2018-2029
1.4.3 Global Virus Cryopreservation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Virus Cryopreservation Market Competition by Manufacturers
2.1 Global Virus Cryopreservation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Virus Cryopreservation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Virus Cryopreservation Average Price by Manufacturers (2018-2023)
2.4 Global Virus Cryopreservation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Virus Cryopreservation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Virus Cryopreservation, Product Type & Application
2.7 Virus Cryopreservation Market Competitive Situation and Trends
2.7.1 Virus Cryopreservation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Virus Cryopreservation Players Market Share by Revenue
2.7.3 Global Virus Cryopreservation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Virus Cryopreservation Retrospective Market Scenario by Region
3.1 Global Virus Cryopreservation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Virus Cryopreservation Global Virus Cryopreservation Sales by Region: 2018-2029
3.2.1 Global Virus Cryopreservation Sales by Region: 2018-2023
3.2.2 Global Virus Cryopreservation Sales by Region: 2024-2029
3.3 Global Virus Cryopreservation Global Virus Cryopreservation Revenue by Region: 2018-2029
3.3.1 Global Virus Cryopreservation Revenue by Region: 2018-2023
3.3.2 Global Virus Cryopreservation Revenue by Region: 2024-2029
3.4 North America Virus Cryopreservation Market Facts & Figures by Country
3.4.1 North America Virus Cryopreservation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Virus Cryopreservation Sales by Country (2018-2029)
3.4.3 North America Virus Cryopreservation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Virus Cryopreservation Market Facts & Figures by Country
3.5.1 Europe Virus Cryopreservation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Virus Cryopreservation Sales by Country (2018-2029)
3.5.3 Europe Virus Cryopreservation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Virus Cryopreservation Market Facts & Figures by Country
3.6.1 Asia Pacific Virus Cryopreservation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Virus Cryopreservation Sales by Country (2018-2029)
3.6.3 Asia Pacific Virus Cryopreservation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Virus Cryopreservation Market Facts & Figures by Country
3.7.1 Latin America Virus Cryopreservation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Virus Cryopreservation Sales by Country (2018-2029)
3.7.3 Latin America Virus Cryopreservation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Virus Cryopreservation Market Facts & Figures by Country
3.8.1 Middle East and Africa Virus Cryopreservation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Virus Cryopreservation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Virus Cryopreservation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Virus Cryopreservation Sales by Type (2018-2029)
4.1.1 Global Virus Cryopreservation Sales by Type (2018-2023)
4.1.2 Global Virus Cryopreservation Sales by Type (2024-2029)
4.1.3 Global Virus Cryopreservation Sales Market Share by Type (2018-2029)
4.2 Global Virus Cryopreservation Revenue by Type (2018-2029)
4.2.1 Global Virus Cryopreservation Revenue by Type (2018-2023)
4.2.2 Global Virus Cryopreservation Revenue by Type (2024-2029)
4.2.3 Global Virus Cryopreservation Revenue Market Share by Type (2018-2029)
4.3 Global Virus Cryopreservation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Virus Cryopreservation Sales by Application (2018-2029)
5.1.1 Global Virus Cryopreservation Sales by Application (2018-2023)
5.1.2 Global Virus Cryopreservation Sales by Application (2024-2029)
5.1.3 Global Virus Cryopreservation Sales Market Share by Application (2018-2029)
5.2 Global Virus Cryopreservation Revenue by Application (2018-2029)
5.2.1 Global Virus Cryopreservation Revenue by Application (2018-2023)
5.2.2 Global Virus Cryopreservation Revenue by Application (2024-2029)
5.2.3 Global Virus Cryopreservation Revenue Market Share by Application (2018-2029)
5.3 Global Virus Cryopreservation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ATCC
6.1.1 ATCC Corporation Information
6.1.2 ATCC Description and Business Overview
6.1.3 ATCC Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ATCC Virus Cryopreservation Product Portfolio
6.1.5 ATCC Recent Developments/Updates
6.2 Kerafast
6.2.1 Kerafast Corporation Information
6.2.2 Kerafast Description and Business Overview
6.2.3 Kerafast Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kerafast Virus Cryopreservation Product Portfolio
6.2.5 Kerafast Recent Developments/Updates
6.3 Virovek
6.3.1 Virovek Corporation Information
6.3.2 Virovek Description and Business Overview
6.3.3 Virovek Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Virovek Virus Cryopreservation Product Portfolio
6.3.5 Virovek Recent Developments/Updates
6.4 Virusys Corporation
6.4.1 Virusys Corporation Corporation Information
6.4.2 Virusys Corporation Description and Business Overview
6.4.3 Virusys Corporation Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Virusys Corporation Virus Cryopreservation Product Portfolio
6.4.5 Virusys Corporation Recent Developments/Updates
6.5 Microbix Biosystems
6.5.1 Microbix Biosystems Corporation Information
6.5.2 Microbix Biosystems Description and Business Overview
6.5.3 Microbix Biosystems Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Microbix Biosystems Virus Cryopreservation Product Portfolio
6.5.5 Microbix Biosystems Recent Developments/Updates
6.6 Eureka Therapeutic
6.6.1 Eureka Therapeutic Corporation Information
6.6.2 Eureka Therapeutic Description and Business Overview
6.6.3 Eureka Therapeutic Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Eureka Therapeutic Virus Cryopreservation Product Portfolio
6.6.5 Eureka Therapeutic Recent Developments/Updates
6.7 Vigene Biosciences
6.6.1 Vigene Biosciences Corporation Information
6.6.2 Vigene Biosciences Description and Business Overview
6.6.3 Vigene Biosciences Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Vigene Biosciences Virus Cryopreservation Product Portfolio
6.7.5 Vigene Biosciences Recent Developments/Updates
6.8 Oxford Biomedica
6.8.1 Oxford Biomedica Corporation Information
6.8.2 Oxford Biomedica Description and Business Overview
6.8.3 Oxford Biomedica Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Oxford Biomedica Virus Cryopreservation Product Portfolio
6.8.5 Oxford Biomedica Recent Developments/Updates
6.9 Cobra Biologics
6.9.1 Cobra Biologics Corporation Information
6.9.2 Cobra Biologics Description and Business Overview
6.9.3 Cobra Biologics Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cobra Biologics Virus Cryopreservation Product Portfolio
6.9.5 Cobra Biologics Recent Developments/Updates
6.10 Lonza
6.10.1 Lonza Corporation Information
6.10.2 Lonza Description and Business Overview
6.10.3 Lonza Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lonza Virus Cryopreservation Product Portfolio
6.10.5 Lonza Recent Developments/Updates
6.11 BioReliance
6.11.1 BioReliance Corporation Information
6.11.2 BioReliance Virus Cryopreservation Description and Business Overview
6.11.3 BioReliance Virus Cryopreservation Sales, Revenue and Gross Margin (2018-2023)
6.11.4 BioReliance Virus Cryopreservation Product Portfolio
6.11.5 BioReliance Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Virus Cryopreservation Industry Chain Analysis
7.2 Virus Cryopreservation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Virus Cryopreservation Production Mode & Process
7.4 Virus Cryopreservation Sales and Marketing
7.4.1 Virus Cryopreservation Sales Channels
7.4.2 Virus Cryopreservation Distributors
7.5 Virus Cryopreservation Customers
8 Virus Cryopreservation Market Dynamics
8.1 Virus Cryopreservation Industry Trends
8.2 Virus Cryopreservation Market Drivers
8.3 Virus Cryopreservation Market Challenges
8.4 Virus Cryopreservation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
